Home » Catalent Pharma Solutions Signs Agreement With ALK-Abello to Expand Zydis Production Capacity
Catalent Pharma Solutions Signs Agreement With ALK-Abello to Expand Zydis Production Capacity
Catalent Pharma Solutions, Inc and Danish pharmaceutical company ALK-Abelló A/S have signed an agreement that will enable a substantial increase in Zydis oral dissolving tablet production capacity dedicated to ALK-Abelló’s immunotherapy products.
Business Wire
Upcoming Events
-
07May
-
14May
-
30May